Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Kelly, Ronan J, Ajani, Jaffer A, Kuzdzal, Jaroslaw, Zander, Thomas, Van Cutsem, Eric, Piessen, Guillaume, Mendez, Guillermo, Feliciano, Josephine, Motoyama, Satoru, Lièvre, Astrid, Uronis, Hope, Elimova, Elena, Grootscholten, Cecile, Geboes, Karen, Zafar, Syed, Snow, Stephanie, Ko, Andrew H, Feeney, Kynan, Schenker, Michael, Kocon, Piotr, Zhang, Jenny, Zhu, Lili, Lei, Ming, Singh, Prianka, Kondo, Kaoru, Cleary, James M, Moehler, Markus
Published in The New England journal of medicine (01.04.2021)
Published in The New England journal of medicine (01.04.2021)
Get full text
Journal Article
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer
Shitara, Kohei, Ajani, Jaffer A, Moehler, Markus, Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz, Bragagnoli, Arinilda Campos, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Bruges, Ricardo, Zander, Thomas, de Azevedo, Sergio, Kowalyszyn, Ruben, Pazo-Cid, Roberto, Schenker, Michael, Cleary, James M, Yanez, Patricio, Feeney, Kynan, Karamouzis, Michalis V, Poulart, Valerie, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Janjigian, Yelena Y
Published in Nature (London) (31.03.2022)
Published in Nature (London) (31.03.2022)
Get full text
Journal Article
Nivolumab (NIVO) plus ipilimumab (IPI) or NIVO plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced esophageal squamous cell carcinoma (ESCC): First results of the CheckMate 648 study
Chau, Ian, Doki, Yuichiro, Ajani, Jaffer A., Xu, Jianming, Wyrwicz, Lucjan, Motoyama, Satoru, Ogata, Takashi, Kawakami, Hisato, Hsu, Chih-Hung, Adenis, Antoine, El Hajbi, Farid, Di Bartolomeo, Maria, Braghiroli, Maria Ignez Freitas Melro, Holtved, Eva, Xynos, Ioannis, Liu, Xuan, Lei, Ming, Kondo, Kaoru, Kato, Ken, Kitagawa, Yuko
Published in Journal of clinical oncology (20.06.2021)
Published in Journal of clinical oncology (20.06.2021)
Get full text
Journal Article
Direct Measure of Fluorescence Intensity for Efficient Receptor-binding Assay: Conjugates of Ethinylcarboxyestradiol and 5(and 6)-Carboxyfluorescein via α,ω-Diaminoalkanes as a Tracer for Estrogen Receptor
Asai, Daisuke, Tokunaga, Takatoshi, Kondo, Kaoru, Kawaguchi, Tsutomu, Takayanagi, Sayaka, Shinmyozu, Teruo, Nakai, Makoto, Yakabe, Yoshikuni, Shimohigashi, Yasuyuki
Published in Journal of biochemistry (Tokyo) (01.06.2008)
Published in Journal of biochemistry (Tokyo) (01.06.2008)
Get full text
Journal Article
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
Janjigian, Yelena Y, Shitara, Kohei, Moehler, Markus, Garrido, Marcelo, Salman, Pamela, Shen, Lin, Wyrwicz, Lucjan, Yamaguchi, Kensei, Skoczylas, Tomasz, Campos Bragagnoli, Arinilda, Liu, Tianshu, Schenker, Michael, Yanez, Patricio, Tehfe, Mustapha, Kowalyszyn, Ruben, Karamouzis, Michalis V, Bruges, Ricardo, Zander, Thomas, Pazo-Cid, Roberto, Hitre, Erika, Feeney, Kynan, Cleary, James M, Poulart, Valerie, Cullen, Dana, Lei, Ming, Xiao, Hong, Kondo, Kaoru, Li, Mingshun, Ajani, Jaffer A
Published in The Lancet (British edition) (03.07.2021)
Published in The Lancet (British edition) (03.07.2021)
Get full text
Journal Article
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma
Doki, Yuichiro, Ajani, Jaffer A, Kato, Ken, Xu, Jianming, Wyrwicz, Lucjan, Motoyama, Satoru, Ogata, Takashi, Kawakami, Hisato, Hsu, Chih-Hung, Adenis, Antoine, El Hajbi, Farid, Di Bartolomeo, Maria, Braghiroli, Maria I, Holtved, Eva, Ostoich, Sandra A, Kim, Hye R, Ueno, Masaki, Mansoor, Wasat, Yang, Wen-Chi, Liu, Tianshu, Bridgewater, John, Makino, Tomoki, Xynos, Ioannis, Liu, Xuan, Lei, Ming, Kondo, Kaoru, Patel, Apurva, Gricar, Joseph, Chau, Ian, Kitagawa, Yuko
Published in The New England journal of medicine (03.02.2022)
Published in The New England journal of medicine (03.02.2022)
Get full text
Journal Article
Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): 36-month results of nivolumab plus chemotherapy (N+C) versus (C) from CheckMate 649
Elimova, Elena, Wyrwicz, Lucjan, Chen, Clara, Blum, Steven Michael, Davenport, Eric, Wang, Jinyi, Kondo, Kaoru, Moehler, Markus H.
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Expression of glutamate transporters in cultured glial cells
Kondo, Kaoru, Hashimoto, Hitoshi, Kitanaka, Jun-ichi, Sawada, Makoto, Suzumura, Akio, Marunouchi, Tohru, Baba, Akemichi
Published in Neuroscience letters (24.03.1995)
Published in Neuroscience letters (24.03.1995)
Get full text
Journal Article
A case of bronchial atresia treated with right S6 segmentectomy using fluorescence navigation with indocyanine green
Watanabe, Mototsugu, Kondo, Kaoru, Furukawa, Shinichi, Shiotani, Toshio, Kataoka, Kazuhiko
Published in General Thoracic and Cardiovascular Surgery Cases (01.12.2022)
Published in General Thoracic and Cardiovascular Surgery Cases (01.12.2022)
Get full text
Journal Article
Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): Results of nivolumab plus chemotherapy (NIVO+chemo) versus chemo from CheckMate 649
Elimova, Elena, Wyrwicz, Lucjan, Blum, Steven I., Xiao, Hong, Li, Mingshun, Kondo, Kaoru, Davenport, Eric, Wang, Jinyi, Hunter, Shannon, Moehler, Markus H.
Published in Journal of clinical oncology (01.10.2021)
Published in Journal of clinical oncology (01.10.2021)
Get full text
Journal Article
Health-Related Quality of Life With Nivolumab Plus Chemotherapy Versus Chemotherapy in Patients With Advanced Gastric/Gastroesophageal Junction Cancer or Esophageal Adenocarcinoma From CheckMate 649
Moehler, Markus, Xiao, Hong, Blum, Steven I, Elimova, Elena, Cella, David, Shitara, Kohei, Ajani, Jaffer A, Janjigian, Yelena Y, Garrido, Marcelo, Shen, Lin, Yamaguchi, Kensei, Liu, Tianshu, Schenker, Michael, Kowalyszyn, Ruben, Bragagnoli, Arinilda Campos, Bruges, Ricardo, Montesarchio, Vincenzo, Pazo-Cid, Roberto, Hunter, Shannon, Davenport, Eric, Wang, Jinyi, Kondo, Kaoru, Li, Mingshun, Wyrwicz, Lucjan
Published in Journal of clinical oncology (10.12.2023)
Published in Journal of clinical oncology (10.12.2023)
Get full text
Journal Article
Health-related quality of life (HRQOL) in patients (pts) with advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC) or esophageal adenocarcinoma (EAC): Interim results of nivolumab plus chemotherapy (N+C) versus (C) from CheckMate 649
Wyrwicz, Lucjan, Elimova, Elena, Blum, Steven I., Xiao, Hong, Davenport, Eric, Wang, Jinyi, Hunter, Shannon, Li, Mingshun, Kondo, Kaoru, Moehler, Markus H.
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Nivolumab (NIVO) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy, safety, and subgroup analyses from CheckMate 649
Shitara, Kohei, Janjigian, Yelena Y., Moehler, Markus H., Garrido, Marcelo, Gallardo, Carlos, Shen, Lin, Yamaguchi, Kensei, Wyrwicz, Lucjan, Skoczylas, Tomasz, Campos Bragagnoli, Arinilda Silva, Liu, Tianshu, Tehfe, Mustapha, Elimova, Elena, Soleymani, Samira, Lei, Ming, Kondo, Kaoru, Li, Mingshun, Ajani, Jaffer A.
Published in Journal of clinical oncology (01.02.2022)
Published in Journal of clinical oncology (01.02.2022)
Get full text
Journal Article